Portage Biotech
PRTG
#10226
Rank
NZ$26.73 M
Marketcap
Country
NZ$11.73
Share price
-2.16%
Change (1 day)
78.45%
Change (1 year)

Portage Biotech (PRTG) - Cash on Hand

Cash on Hand as of March 2025 : NZ$2.87 Million

According to Portage Biotech's latest financial reports the company has NZ$2.87 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Portage Biotech - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31NZ$2.94 M-64.93%
2024-03-31NZ$8.39 M-50.12%
2023-03-31NZ$16.83 M-50%
2022-03-31NZ$33.67 M749.06%
2021-03-31NZ$3.96 M-26.69%
2020-03-31NZ$5.41 M-41.1%
2019-03-31NZ$9.18 M-12.21%
2018-03-31NZ$10.46 M-87.58%
2017-03-31NZ$84.22 M1143.19%
2016-03-31NZ$6.77 M193.57%
2015-03-31NZ$2.3 M-1.46%
2014-03-31NZ$2.34 M-40.89%
2013-03-31NZ$3.96 M1034.67%
2012-03-31NZ$0.34 M-88.52%
2011-03-31NZ$3.04 M-41.73%
2010-03-31NZ$5.22 M158.74%
2009-03-31NZ$2.01 M-65.88%
2008-03-31NZ$5.91 M-22.9%
2007-03-31NZ$7.66 M7.35%
2006-03-31NZ$7.14 M556.34%
2005-03-31NZ$1.08 M90.34%
2004-03-31NZ$0.57 M2241.54%
2003-03-31NZ$0.02 M-64.02%
2002-03-31NZ$0.06 M-46.09%
2001-03-31NZ$0.12 M-91.94%
2000-03-31NZ$1.56 M875.99%
1999-03-31NZ$0.16 M2103.45%
1998-03-31NZ$0 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NRC Health
NRC
NZ$3.82 M 32.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
NZ$0.22 M-92.10% Bahamas